For the full-year 2021, we now expect revenue in the range of $5.7 billion to $5.9 billion, expected adjusted EBITDA to be in the range of $870 million to $900 million and expected earnings per common share to be in the range of $2.41 to $2.58.
Earnings per common share increased 105% to $0.82 for the first quarter, compared to $0.40 for the same quarter last year.
Net income attributable to Select Medical Holdings was $110.5 million in the first quarter, and earnings per common share was $0.82.
For the full-year 2021, we now expect revenue in the range of $5.7 billion to $5.9 billion, expected adjusted EBITDA to be in the range of $870 million to $900 million and expected earnings per common share to be in the range of $2.41 to $2.58.
Overall, our net revenue for the first quarter increased 9.3% to $1.55 billion.
Earnings per common share increased 105% to $0.82 for the first quarter, compared to $0.40 for the same quarter last year.
Net income attributable to Select Medical Holdings was $110.5 million in the first quarter, and earnings per common share was $0.82.
